nasdaq edit stock forecast
Read our earnings report guide before you consider the forecast. Editas Medicine last posted its earnings data on August 3rd 2022.
How To Add Edit Stocks Shown On Notification Center Of Iphone Osxdaily
The forecast for beginning of January 10308.
. Turning to Wall Street Qualcomm has a Moderate Buy consensus rating. Averaged NASDAQ value for. According to 24 stock analysts the average 12-month stock price forecast for EDIT stock is 3045 which predicts an increase of 16478.
EDIT Stock Price Prediction. Nasdaq Global Select Sector. The reported 078 earnings per share EPS for the quarter topping analysts consensus estimates of.
9878 Upside Based on 7 Wall Street analysts offering 12 month price targets for Editas Medicine in the last 3 months. The average price target is. NASDAQEDITs beta value is holding at 201 while the average true range ATR indicator is currently reading 088.
9 2022 when the stock price was at 1583. Editas Medicine Inc. The average Qualcomm price.
According to 23 analysts the average rating for EDIT stock is Buy The 12-month stock price forecast is 3288 which is an increase of 16116 from the. Stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. Stock Price Forecast.
Biotechnology Editas Medicine Inc Price Forecast Insider Ratings Fundamentals. Maximum value 11252 while minimum 9978. EDIT Editas Medicines forecast annual revenue growth rate of 2864 is forecast to beat the US Biotechnology industrys average forecast revenue growth rate of 2234 and and.
It is engaged in. Based on our forecasts a long-term increase is expected the EDIT stock price prognosis for 2027-04-16 is 28373 USD. High Growth Revenue.
Find market predictions EDIT financials and market news. Editas Medicine Inc EDIT Exchange. EDITs revenue 503 per year is forecast to grow faster than the US market 69 per year.
In the short term 2weeks EDITs stock. EDIT Stock Forecast Price Target for 2023 TradingView. The current Editas Medicine.
See more on advanced chart. Thats based on 15 Buys and six Holds assigned in the past three months. Markets US Stocks Health Technology Biotechnology EDIT.
The 14 analysts offering 12-month price forecasts for Editas Medicine Inc have a median target of 2150 with a high estimate of 8000 and a low estimate of 800. See Editas Medicine Inc. Skip to main.
EDITs revenue 503 per year is forecast to grow. EDIT stock forecast Our latest prediction for Editas Medicine Incs stock price was made on the Sept. 26 rows NASDAQ predictions for January 2023.
Society Pass Inc Nasdaq. Find the latest Earnings Report Date for Editas Medicine Inc. View live Editas Medicine Inc chart to track its stocks price action.
Edit Editas Medicine Inc Stock Overview U S Nasdaq Barron S
Editas Medicine Edit Stock Price News Info The Motley Fool
Down 35 This Year Is This Small Cap Stock A Buy Nasdaq
3 Stock Market Predictions For Another Year Like No Other Nasdaq
Stock Price Simulation Using Monte Carlo Methods Alteryx Community
Investors One Year Losses Grow To 78 As The Stock Sheds Us 94m This Past Week
Is Editas Medicine A Buy The Motley Fool
Costco Stock Nasdaq Cost A Hedge Against A Potential Recession Nasdaq
Where Will Editas Medicine Be In 5 Years Nasdaq
Stock Market Forecast For The Next Six Months Poses New Risks For Investors Investor S Business Daily
Editas Medicine Edit 5 Price Charts 2016 2022 History
Stock Quote Apps On Google Play
Intellia Stock Best All Around Gene Editing Company Nasdaq Ntla Seeking Alpha
Electronics Free Full Text Stock Market Prediction Using Machine Learning Techniques A Decade Survey On Methodologies Recent Developments And Future Directions
Editas Medicine Another Undervalued Crispr Gene Editing Company Nasdaq Edit Seeking Alpha
Editas Medicine Inc Edit Stock Price Us28106w1036 Marketscreener
Edit Editas Medicine Inc Stock Overview U S Nasdaq Barron S
Editas Medicine Nasdaq Edit Price Target Cut To 10 00 By Analysts At Morgan Stanley Etf Daily News